Causes of death among HIV infected adults in French Guyana and the French West Indies in the era of highly active antiretroviral therapy (HAART);Causes de décès des adultes infectés par le VIH dans les départements français d'Amérique à l'ère des traitements antirétroviraux hautement actifs

Medecine et Maladies Infectieuses

Volumn 34, Issue 7, 2004, Pages 286-292

  Lewden, C ^a   Sobesky, M ^b   Cabie A ^b   Couppie P ^c   Boulard, F ^d   Bissuel, F ^e   May, T ^f   Morlat, P ^g   Chene G ^a   Lamaury, I ^b   Salmon, D ^h  

^a INSERM   (France)

^b CISIH   (France)

^c Hôpital Les Flamboyants   (France)

^d Basse Terre   (France)

^e Hôpital André Bouron   (France)

^f CHU NANCY BRABOIS   (France)

^g HÔPITAL SAINT ANDRÉ   (France)

^h Institut Cochin   (France)

Author keywords

AIDS; Cause de d c s; Cause of death; HAART; HIV Infection; Infection par le VIH; Mortalit ; Mortality; Sida

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALCOHOLISM; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BACTERIAL INFECTION; CARDIOVASCULAR DISEASE; CARIBBEAN ISLANDS; CIGARETTE SMOKING; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DEATH; DISEASE SEVERITY; FEMALE; FREQUENCY ANALYSIS; GUYANA; HEPATITIS; HETEROSEXUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; LIVER DISEASE; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; TOXOPLASMOSIS; TUBERCULOSIS; VIRUS TRANSMISSION; WARD;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CAUSE OF DEATH; FEMALE; FRENCH GUIANA; HIV INFECTIONS; HUMANS; MALE; PROSPECTIVE STUDIES; VITAL STATISTICS;

EID: 4644357527     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.medmal.2004.05.002     Document Type: Article

References (9)

1. Lewden C., Bvilacqua S., and Bonnet F. Causes of death in HIV-infected adults in the era of highly active antiretroviral therapy (HAART), the French survey Mortalit 2000 2nd IAS Conference on HIV Pathogenesis and Treatment, 1316July abstract 88 Antiviral Therapy 8 2003 S208
2. Institut de Veille Sanitaire Surveillance du sida en France, situation au 31mars 2002 Bull epidmiol Hebd 2002 133 139
3. Delfraissy J. Prise en charge des personnes infectes par le VIH 2002 Flammarion Paris Recommandations du groupe d'experts. Rapport 2002. Mdecine Sciences ed
4. Direction générale de la santé. Stratégie de prévention de l'infection VIH/sida en France pour les années 2001-2004. 2001 [cited 31/07/2003]. Available from Internet, http://www.sante.gouv.fr/htm/actu/siphilis/strat2001_04.pdf Available from Internet
5. Couppi P., Clyti E., El Guedj M., Sobesky M., and Pradinaud R. Social factors associated with bad follow-up with HIV+ patients in French Guiana ternational Aids Society XIIIth International AIDS conference; 2000 july; Durban, South Africa 2000 MoPeD2648
6. Delaneau J., Bimbenet J., and Boyer L. Rapport d'information 246 Commission des affaires sociales Snat http://www.senat.fr/rap/r99-246/r99-246. html 2000 [cited 11/08/2003] Available from Internet
7. McKinsey D., Wheat L., and Cloud G. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study National Institute of Allergy and Infectious Diseases Mycoses Study Group Clin Infect Dis 28 1999 1049 1056
8. Savs M., Chne G., and Ducimetiere P. Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population Clin Infect Dis 37 2003 292 298
9. Failde I., Balkau B., and Costagliola D. Arterial hypertension in the adult population of Guadeloupe, and associated factors in subjects of African origin Rev Epidmiol Sant Publique 44 1996 417 426